Domov › Rakovina močového mechúra › New Jersey
Klinické štúdie Rakovina močového mechúra v štáte New Jersey
26 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v štáte New Jersey.
Mestá v štáte New Jersey
Oficiálny text štúdie (anglicky)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Hackensack University Medical Center, Hackensack
- Memorial Sloan Kettering Monmouth, Middletown
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- a 6 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06770582Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Jefferson Cherry Hill Hospital, Cherry Hill
- Hunterdon Medical Center, Flemington
- Jersey City Medical Center, Jersey City
- a 5 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT03866382A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07206225A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Astera, LLC, East Brunswick
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Morristown Memorial Hospital ( Site 0795), Morristown
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Astera Cancer Care, East Brunswick
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380A Study of Surgical Techniques During Cystectomy
- Memorial Sloan Kettering at Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only), Middletown
- Memorial Sloan Kettering Bergen (Consent Only), Montvale
Prebieha náborFáza 3
Vek 21 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06703476ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Rutgers Cancer Institute of New Jersey ( Site 0007), New Brunswick
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07222488Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Rutgers Cancer Institute, New Brunswick
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07144319Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Hackensack University Medical Center, Hackensack
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06567743A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05837767Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07097142Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)
- Rutgers Cancer Institute, New Brunswick
Prebieha náborFáza 2
Vek 18 až 90 · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT07762586LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Rutgers Cancer Institute of New Jersey, New Brunswick
- New Jersey Urology, LLC, Voorhees Township
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT04752722A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 7. 2026 · NCT07646847A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
Prebieha náborFáza 2
Vek 8 a viac · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT05503797A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT04879329Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Summit Health, Voorhees Township
Prebieha nábor
Vek 18 až 88 · Všetky pohlavia · Aktualizované 2. 7. 2026 · NCT06394869SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
- Rutgers Cancer Institute, New Brunswick
Prebieha náborFáza 2
Vek 18 až 99 · Všetky pohlavia · Aktualizované 6. 5. 2026 · NCT06822010A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 4. 2026 · NCT05562791A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Hackensack University Medical Center, Hackensack
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT06778863SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.